Your browser doesn't support javascript.
loading
Carbon-14 Labeling Synthesis of RORγt Inhibitor JNJ-61803534.
Song, Fengbin; Salter, Rhys; Chen, Lu.
Affiliation
  • Song F; Therapeutics Discovery, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • Salter R; Therapeutics Discovery, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
  • Chen L; Therapeutics Discovery, Janssen Research and Development LLC, Spring House, Pennsylvania, USA.
J Labelled Comp Radiopharm ; 67(8): 288-294, 2024 Jun 30.
Article in En | MEDLINE | ID: mdl-38803015
ABSTRACT
Carbon-14 labeling synthesis of RORγt inhibitor JNJ-61803534 (1) was accomplished in four steps with the C14 label located at the thiazole-2-carboxamide carbon. The synthesis featured a highly efficient conversion of nitrile [14C]-12 to ester [14C]-17 under mild conditions via an imidate intermediate, overcoming the unsuccessful direct hydrolysis of nitrile 12 under either acidic or basic conditions. Since carbon-14 labeling via [14C]-nitrile installation and subsequent conversion to [14C]-carboxylic acid derivatives is a common labeling strategy, an efficient conversion of a nitrile to an ester under mild conditions could be of use for the future C14 labeling syntheses.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbon Radioisotopes / Nuclear Receptor Subfamily 1, Group F, Member 3 Language: En Journal: J Labelled Comp Radiopharm Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbon Radioisotopes / Nuclear Receptor Subfamily 1, Group F, Member 3 Language: En Journal: J Labelled Comp Radiopharm Year: 2024 Document type: Article